paclitaxel has been researched along with Nasal Septal Perforation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Arakaki, Y; Kudaka, W; Nakamoto, T; Nakasone, T; Shimoji, Y; Taira, Y | 1 |
| Cruz, JJ; Gomez, A; Lozano, R; Martin, T; Rodriguez, CA | 1 |
2 other study(ies) available for paclitaxel and Nasal Septal Perforation
| Article | Year |
|---|---|
A case of nasal septal perforation caused by bevacizumab for advanced cervical cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Female; Humans; Middle Aged; Nasal Septal Perforation; Paclitaxel; Uterine Cervical Neoplasms | 2021 |
Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Nasal Septal Perforation; Neoplasm Metastasis; Paclitaxel | 2017 |